Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition.
Leonard SchmiesterFara Brasó-MaristanyBlanca Gonzalez-FarreTomás PascualJoaquín GaviláXavier TekpliJürgen GeislerVessela N KristensenArnoldo FrigessiAleix PratAlvaro Köhn-LuquePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
A mathematical modeling approach accurately predicts patient outcome following CDK4/6i plus endocrine therapy, which marks a step towards more personalized treatments in patients with Luminal B breast cancer.